miR-20b通过调控MAPK/ERK信号通路在甲状腺乳头状癌中发挥抑癌功能
该研究检测了47对甲状腺乳头状癌(PTC)及癌旁正常甲状腺组织中miR-20b的表达,发现其在癌组织中显著下调,低表达与颈部淋巴结转移和TNM分期相关。在K1和TPC-1细胞中过表达miR-20b可抑制细胞活力、迁移和侵袭,并通过直接靶向SOS1和ERK2抑制MAPK/ERK通路;裸鼠移植瘤实验中过表达miR-20b可抑制肿瘤生长。
要点
- miR-20b在PTC组织中较癌旁正常甲状腺组织显著下调。
- miR-20b低表达与颈部淋巴结转移及TNM分期相关。
- miR-20b通过靶向SOS1和ERK2抑制MAPK/ERK通路及PTC细胞恶性表型。
核心结论
- 结果首次表明miR-20b在PTC中发挥抑癌功能。
- miR-20b通过靶向SOS1和ERK2抑制MAPK/ERK信号通路活性。
- 作者认为miR-20b可能在PTC发生、进展和转移中起重要作用,并可能提供潜在治疗靶点。
研究设计与样本
- 研究采用定量逆转录聚合酶链反应检测47对PTC与癌旁正常甲状腺组织中miR-20b的表达。
- 在PTC细胞系K1和TPC-1中过表达miR-20b,评估对细胞活力、迁移和侵袭的影响。
- 研究进一步寻找miR-20b的靶点并鉴定其在PTC细胞中的可能分子机制。
- 此外评估了miR-20b对裸鼠肿瘤生长的影响。
主要发现
- miR-20b在PTC组织中较癌旁正常甲状腺组织显著下调。
- miR-20b低表达与颈部淋巴结转移和TNM分期相关。
- 在K1和TPC-1细胞中上调miR-20b抑制细胞活力、迁移和侵袭。
- miR-20b过表达通过直接靶向SOS1和ERK2抑制MAPK/ERK信号通路。
- 用siRNA敲低SOS1或ERK2对细胞活力和侵袭的作用与miR-20b过表达相似,而恢复SOS1或ERK2表达部分逆转miR-20b在TPC细胞系中的抑制作用。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: MicroRNAs (miRNAs) are endogenous, small, non-coding RNAs that play important roles in multiple biological processes. MiR-20b has been reported to be dysregulated in papillary thyroid carcinoma (PTC). However, the functional roles are still largely unknown. This study aimed to investigate the biological functions and the underlying molecular mechanisms of miR-20b in PTC. METHOD: The expression of miR-20b was assessed by quantitative reverse transcription polymerase chain reaction in 47 pairs of PTC and adjacent normal thyroid tissues. The association between miR-20b expression and clinicopathologic status of PTC patients was analyzed. MiR-20b was overexpressed in the PTC cell lines K1 and TPC-1, and the effects on cell viability, migration, and invasion were evaluated. The study further searched for targets of miR-20b, and identified the possible molecular mechanisms of miR-20b in PTC cells. Additionally, the effect of miR-20b on tumor growth in nude mice was assessed. RESULTS: It was found that miR-20b was markedly downregulated in PTC tissues compared with their adjacent normal thyroid tissues. The low-level expression of miR-20b was correlated with cervical lymph node metastasis and TNM staging. Upregulation of miR-20b inhibited cell viability, migration, and invasion in K1 and TPC-1 cells. Ectopic overexpression of miR-20b could suppress the mitogen-activated protein kinase/extracellular signal-regulated kinase (MAPK/ERK) signaling pathway through directly targeting son of sevenless homolog 1 (SOS1) and extracellular signal-regulated kinase 2 (ERK2). Furthermore, depletion of SOS1 or ERK2 by siRNAs has similar effects as miR-20b overexpression on cell viability and invasion, whereas rescued SOS1 or ERK2 expression partially reversed the inhibitory effects of miR-20b in TPC cell lines. In xenograft animal experiments, it was found that overexpressed miR-20b could suppress tumor growth of PTC cells. CONCLUSION: These results indicate for the first time that miR-20b displays tumor-suppressor functions in PTC. By targeting SOS1 and ERK2, miR-20b inhibits the activity of the MAPK/ERK signaling pathway. The findings suggest that miR-20b may play an important role in PTC initiation, progression, and metastasis, and may provide a potential therapeutic target for PTC.
引用
- Hong S, Yu S, Li J, et al. MiR-20b Displays Tumor-Suppressor Functions in Papillary Thyroid Carcinoma by Regulating the MAPK/ERK Signaling Pathway. Thyroid. 2016. PMID: 27717302
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。